Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA
by on Friday, February 10th, 2012 | No Comments
Condition: Prostate Cancer
Interventions: Drug: Androgen Ablation; Drug: Cabazitaxel; Drug: Salvage Therapy; Drug: Neoadjuvant Treatment - Hormonal Therapy; Drug: Neoadjuvant Treatment - Cabazitaxel
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; Sanofi-Aventis
Not yet recruiting – verified February 2012
Read more here: Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA